|
Distance Education to Engage Alaskan Community Health Aides in Cancer Control
|
5R25CA186882-05
|
$135,579
|
|
CUEVA, MELANY
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-19
|
$417,500
|
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
RCT of An Internet Cessation Program Plus Online Social Network for HIV + Smokers
|
5R01CA192954-05
|
$626,669
|
|
SHUTER, JONATHAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-06
|
$346,525
|
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-03
|
$655,095
|
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Arizona Cancer and Evolution Center (ACE)
|
1U54CA217376-01A1
|
$1,906,167
|
|
MALEY, CARLO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Modeling Neoplastic Progression in Barretts Esophagus
|
5R01CA140657-10
|
$350,771
|
|
MALEY, CARLO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Role of IRF8 in Tumor Rejection and Suppression
|
5R01CA133085-09
|
$307,800
|
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression
|
5R01CA182518-05
|
$315,400
|
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-05
|
$456,456
|
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Clinical Research Training Program
|
5K12CA090433-17
|
$827,164
|
|
BLANEY, SUSAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Crosstalk between the ER Stress Response and Mitochondrial Fatty Acid Oxidation in MYC-driven Breast Cancer
|
1R37CA228304-01
|
$362,569
|
|
CHEN, XI
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
|
5R01CA219667-02
|
$523,048
|
|
DUMAN, JOSEPH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-04
|
$119,807
|
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
5R01CA215452-02
|
$362,569
|
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
|
5R01CA116548-13
|
$249,638
|
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Metabolic Regulation in Leukemia-Initatiating Cells
|
5R01CA193235-04
|
$462,191
|
|
NAKADA, DAISUKE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers
|
1R01CA216426-01A1
|
$427,819
|
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
|
5R01CA181808-05
|
$336,565
|
|
RICHARDS, JOANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-22
|
$372,400
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer
|
5R01CA202797-03
|
$349,694
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-04
|
$604,525
|
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-05
|
$721,537
|
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Integration of Palliative Care for Cancer Patients on Phase I Trials
|
5R01CA177562-05
|
$1,384,347
|
|
FERRELL, BETTY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
5R01CA213138-02
|
$395,738
|
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
|
1R01CA217841-01A1
|
$717,367
|
|
SUN, VIRGINIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Risk factors for molecular subtypes of NHL a prospective evaluation
|
5R01CA202712-03
|
$668,277
|
|
WANG, SOPHIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
|
1R01CA228465-01
|
$404,275
|
|
ZENG, DEFU
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-03
|
$470,573
|
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-13
|
$2,300,000
|
$276,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
|
1R01CA218382-01A1
|
$668,549
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-03
|
$522,325
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Randomized Trial of a Mammography Decision Aid for Women Aged 75 and Older
|
5R01CA181357-05
|
$414,552
|
|
SCHONBERG, MARA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Regulation of the LIN28/let-7 pathway in cancer
|
1R01CA211328-01
|
$404,888
|
$404,888
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL
|
5R01CA193651-04
|
$443,296
|
|
GUTIERREZ, ALEJANDRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
CXCR3-B-mediated novel growth-inhibitory signals in breast cancer cells
|
1R03CA215926-01A1
|
$88,500
|
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Identification of susceptibility to chemotherapy induced peripheral neuropathy using patient stem cell derived sensory neurons
|
5R03CA220219-02
|
$88,500
|
|
WOOLF, CLIFFORD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future
|
1R01CA227576-01
|
$460,299
|
|
YEH, JENNIFER
|
BOSTON CHILDREN'S HOSPITAL
|
|
Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications
|
1R01CA224911-01A1
|
$715,647
|
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
|
1R01CA227433-01
|
$608,862
|
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Clinical Feasibility of Chemotherapy Monitoring for Sarcoma with Diffuse Optical Spectroscopic Imaging
|
1F31CA221074-01A1
|
$38,082
|
|
PETERSON, HANNAH
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developing a translational pipeline for NF1-mutant malignancies
|
5U01CA202943-03
|
$235,046
|
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-10
|
$3,474,603
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Wilm's Tumor for this search: $5,581,872
|